Catalyst Pharmaceuticals, Inc.

Brandywine Global Investment Management, LLC CPRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

300,116

Value ($000)

7,005

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	7,005	0.0%	300,116	12/31/2025
2024 Q3	11/12/2024	8,093	0.1%	392,118	9/30/2024
2024 Q2	8/14/2024	6,748	0.1%	435,631	6/30/2024
2024 Q1	5/13/2024	5,920	0.0%	371,383	3/31/2024
2023 Q4	2/9/2024	3,001	0.0%	178,530	12/31/2023
2023 Q3	11/13/2023	2,539	0.0%	217,209	9/30/2023
2023 Q2	8/11/2023	2,856	0.0%	212,509	6/30/2023
2023 Q1	5/12/2023	3,540	0.0%	213,509	3/31/2023
2022 Q4	2/10/2023	3,971	0.0%	213,509	12/31/2022
2022 Q3	11/14/2022	2,739	0.0%	213,509	9/30/2022
2022 Q2	8/11/2022	1,558	0.0%	222,267	6/30/2022
2022 Q1	5/13/2022	2,111	0.0%	254,667	3/31/2022
2021 Q4	2/11/2022	1,724	0.0%	254,667	12/31/2021
2021 Q3	11/12/2021	1,864	0.0%	351,642	9/30/2021
2021 Q2	8/13/2021	2,010	0.0%	349,628	6/30/2021
2021 Q1	5/13/2021	1,631	0.0%	353,887	3/31/2021
2020 Q4	2/10/2021	1,193	0.0%	357,325	12/31/2020
2020 Q3	11/12/2020	1,336	0.0%	449,680	9/30/2020
2020 Q2	8/14/2020	1,575	0.0%	340,790	6/30/2020
2020 Q1	5/15/2020	1,300	0.0%	337,562	3/31/2020
2019 Q4	2/14/2020	1,265	0.0%	335,412	12/31/2019